Literature DB >> 28820685

Immune Reconstitution Inflammatory Syndrome in HIV-Infected Immigrants.

María Pérez-Rueda1, Michele Hernández-Cabrera2,3, Adela Francés-Urmeneta2, Alfonso Angel-Moreno4, Elena Pisos-Álamo2,3, Nieves Jaén-Sánchez2,3, Cristina Carranza-Rodríguez2,3, Jose-Luis Pérez-Arellano3,2.   

Abstract

Immune reconstitution inflammatory syndrome (IRIS) includes a group of potentially serious inflammatory processes that may be present in HIV-infected patients after initiating highly active antiretroviral therapy (HAART). Paradoxical IRIS is a worsening of symptoms, after an overwhelming response to a previously diagnosed opportunistic infection (OI); unmasking IRIS reveals a previously occult OI. The main objective of the study was to describe the epidemiological, clinical, and outcome data of HIV-infected immigrants, stratified according to high- or low-income countries of origin, who developed IRIS and to compare them with native-born Spanish patients. This retrospective study reviewed all patients with HIV infection admitted to the Unit of Infectious Diseases and Tropical Medicine between 1998 and 2014. IRIS was identified in 25/138 (18%) immigrant patients and 24/473 (5%) native-born Spanish patients infected with HIV. Most cases, 19/25 (76%), were of unmasking IRIS. The time elapsed between initiation of HAART and development of IRIS was significantly longer in patients with unmasking versus paradoxical IRIS. OIs, in particular due to mycobacteria, were the most frequently involved processes. Twenty percent of patients died. The comparison of immigrant and native-born patients found significant differences for both IRIS type (higher incidence of paradoxical forms among immigrants) and for the absence of malignancies in native-born patients. No significant differences were found when the data of immigrants from low- and high-income countries were compared.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28820685      PMCID: PMC5637585          DOI: 10.4269/ajtmh.16-0773

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

1.  Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis.

Authors:  Carolina Garcia Vidal; Serena Rodríguez Fernández; Javier Martínez Lacasa; Miquel Salavert; Rafael Vidal; Monica Rodríguez Carballeira; Javier Garau
Journal:  Clin Infect Dis       Date:  2005-02-04       Impact factor: 9.079

2.  Leprosy after starting antiretroviral treatment.

Authors:  Stephen D Lawn; Diana N J Lockwood
Journal:  BMJ       Date:  2007-02-03

3.  Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

4.  CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts.

Authors:  Elvin H Geng; Steven G Deeks
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

5.  An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.

Authors:  Nina Singh; Olivier Lortholary; Barbara D Alexander; Krishan L Gupta; George T John; Kenneth Pursell; Patricia Munoz; Goran B Klintmalm; Valentina Stosor; Ramon del Busto; Ajit P Limaye; Jyoti Somani; Marshall Lyon; Sally Houston; Andrew A House; Timothy L Pruett; Susan Orloff; Atul Humar; Lorraine Dowdy; Julia Garcia-Diaz; Andre C Kalil; Robert A Fisher; Shahid Husain
Journal:  Clin Infect Dis       Date:  2005-04-29       Impact factor: 9.079

Review 6.  Missing infections in AIDS.

Authors:  S B Lucas
Journal:  Trans R Soc Trop Med Hyg       Date:  1990       Impact factor: 2.184

7.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Fehmida Visnegarwala; Jorge Darcourt; Edward A Graviss; Thomas P Giordano; A Clinton White; Richard J Hamill
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

8.  Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia.

Authors:  Jose Cadena; George R Thompson; Tony T Ho; Edward Medina; Darrel W Hughes; Thomas F Patterson
Journal:  Diagn Microbiol Infect Dis       Date:  2009-07       Impact factor: 2.803

9.  Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.

Authors:  David M Murdoch; Willem D F Venter; Charles Feldman; Annelies Van Rie
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

10.  Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.

Authors:  Joseph N Jarvis; Tihana Bicanic; Angela Loyse; Daniel Namarika; Arthur Jackson; Jesse C Nussbaum; Nicky Longley; Conrad Muzoora; Jacob Phulusa; Kabanda Taseera; Creto Kanyembe; Douglas Wilson; Mina C Hosseinipour; Annemarie E Brouwer; Direk Limmathurotsakul; Nicholas White; Charles van der Horst; Robin Wood; Graeme Meintjes; John Bradley; Shabbar Jaffar; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2013-12-06       Impact factor: 9.079

View more
  5 in total

Review 1.  JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.

Authors:  Vijay Harypursat; Yihong Zhou; Shengquan Tang; Yaokai Chen
Journal:  AIDS Res Ther       Date:  2020-07-06       Impact factor: 2.250

2.  Hemophagocytic syndrome in patients infected with the human immunodeficiency virus: A study of 15 consecutive patients.

Authors:  L Suárez-Hormiga; M N Jaén-Sánchez; E A Verdugo-Espinosa; C Carranza-Rodríguez; P M Hernández-Cabrera; E Pisos-Álamo; A Francés-Urmeneta; J L Pérez-Arellano
Journal:  Rev Esp Quimioter       Date:  2020-06-19       Impact factor: 1.553

3.  Rapid onset of hypercalcemia from high-grade lymphoma in the setting of HIV-related immune reconstitution inflammatory syndrome.

Authors:  Stephanie J Kim; Michael J Peluso; Yongmei Wang; Daniel Bikle; Dolores Shoback; Sarah Kim
Journal:  Bone Rep       Date:  2018-12-28

4.  A rare entity of reactive arthritis-immune reconstitution inflammatory syndrome in an immunocompromised patient.

Authors:  Christine Katusiime
Journal:  Clin Case Rep       Date:  2019-06-23

5.  Different Trends of Distinct Time Points of AIDS Events Following HIV Diagnosis in Various At-risk Populations: A Retrospective Nationwide Cohort Study in Taiwan.

Authors:  Chun-Yuan Lee; Pei-Hua Wu; Po-Liang Lu; Fu-Wen Liang
Journal:  Infect Dis Ther       Date:  2021-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.